153108-98-6

Basic information

• Product Name: N-<(benzyloxy)carbonyl>-2-<2-(tert-butyldimethylsiloxy)ethyl>piperidine
• Synonyms: N-<(benzyloxy)carbonyl>-2-<2-(tert-butyldimethylsiloxy)ethyl>piperidine
• CAS NO: 153108-98-6
• Molecular Weight: 377.599
• Mol File: 153108-98-6.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: N-<(benzyloxy)carbonyl>-2-<2-(tert-butyldimethylsiloxy)ethyl>piperidine(CAS DataBase Reference)
• NIST Chemistry Reference: N-<(benzyloxy)carbonyl>-2-<2-(tert-butyldimethylsiloxy)ethyl>piperidine(153108-98-6)
• EPA Substance Registry System: N-<(benzyloxy)carbonyl>-2-<2-(tert-butyldimethylsiloxy)ethyl>piperidine(153108-98-6)

Safety Data

• Hazardous Substances Data: 153108-98-6(Hazardous Substances Data)

Upstream product

• 1484-84-0 2(RS)-(2-hydroxyethyl)piperidine 
• 18162-48-6 tert-butyldimethylsilyl chloride 
• 501-53-1 benzyl chloroformate 
• 39945-50-1 2-(2-hydroxyethyl)-piperidine-1-carboxylic acid benzyl ester 

Downstream Products

• 1374006-92-4 N-(4-((2-(2-hydroxyethyl)piperidin-1-yl)sulfonyl)phenyl)-1-methyl-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide 
• 1374006-95-7 1-methyl-N-(4-((2-(2-morpholinoethyl)piperidin-1-yl)sulfonyl)phenyl)-3-(trifluoromethyl)pyrazole-5-carboxamide 
• 1374007-02-9 C₁₉H₃₄N₂O₃SSi 

Relevant articles and documents

MYXOVIRUS THERAPEUTICS, COMPOUNDS, AND USES RELATED THERETO

This disclosure relates to antiviral compounds disclosed herein and uses related thereto. In certain embodiments, the disclosure relates to pharmaceutical compositions. Typically, the pharmaceutical composition comprises a compound of formula I: Formula I

NEW BRADYKININ B1 ANTAGONISTS

The invention relates to compounds of formula (I), wherein R1 to R5 and X1 to X4, n and m have the meaning as cited in the description and the claims. Said compounds are useful as Bradykinin B1 antagonists. The